- United States
- /
- Life Sciences
- /
- NasdaqGS:ILMN
Jacob Thaysen Bought 94% More Shares In Illumina
Illumina, Inc. (NASDAQ:ILMN) shareholders (or potential shareholders) will be happy to see that the CEO & Director, Jacob Thaysen, recently bought a whopping US$999k worth of stock, at a price of US$80.86. That purchase boosted their holding by 94%, which makes us wonder if the move was inspired by quietly confident deeply-felt optimism.
We check all companies for important risks. See what we found for Illumina in our free report.Illumina Insider Transactions Over The Last Year
Notably, that recent purchase by Jacob Thaysen is the biggest insider purchase of Illumina shares that we've seen in the last year. That means that an insider was happy to buy shares at around the current price of US$83.62. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the Illumina insiders decided to buy shares at close to current prices.
Illumina insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
See our latest analysis for Illumina
Illumina is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
Does Illumina Boast High Insider Ownership?
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Illumina insiders own 2.7% of the company, currently worth about US$349m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Does This Data Suggest About Illumina Insiders?
The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. When combined with notable insider ownership, these factors suggest Illumina insiders are well aligned, and quite possibly think the share price is too low. Nice! Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Illumina.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:ILMN
Illumina
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Excellent balance sheet and fair value.
Similar Companies
Market Insights
Weekly Picks

Is this the AI replacing marketing professionals?
Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business
The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery Â
The Infrastructure AI Cannot Be Built Without
Recently Updated Narratives
Promigas E.S.P looks to a promising future with 35% revenue growth

Kratos Defense & Security Solutions (KTOS): Scaling "Attritable" Dominance in a New Era of Aerial Conflict.

BWX Technologies (BWXT): Powering the Nuclear Renaissance from Naval Depths to Medical Frontiers.
Popular Narratives
Nu holdings will continue to disrupt the South American banking market

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
